Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality

Background. Infection is a serious complication of tunnelled cuffed catheter (TCC) use and is associated with high complication and mortality rates. Although attempts at TCC salvage after bacteraemia have been associated with high rates of recurrent bacteraemia, there have been no large studies in w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nephrology, dialysis, transplantation dialysis, transplantation, 2006-04, Vol.21 (4), p.1024-1031
Hauptverfasser: Mokrzycki, Michele H., Zhang, Meilin, Cohen, Hillel, Golestaneh, Ladan, Laut, Jeffrey M., Rosenberg, Stuart O.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1031
container_issue 4
container_start_page 1024
container_title Nephrology, dialysis, transplantation
container_volume 21
creator Mokrzycki, Michele H.
Zhang, Meilin
Cohen, Hillel
Golestaneh, Ladan
Laut, Jeffrey M.
Rosenberg, Stuart O.
description Background. Infection is a serious complication of tunnelled cuffed catheter (TCC) use and is associated with high complication and mortality rates. Although attempts at TCC salvage after bacteraemia have been associated with high rates of recurrent bacteraemia, there have been no large studies in which multivariate analysis has been performed to control for confounding factors such as infecting organisms, diabetes, etc. Methods. A prospective observational study was performed in chronic HD patients dialyzing with a TCC at seven outpatient HD centers. All patients diagnosed with TCC bacteraemia were observed for 3 months following initial presentation and outcomes were recorded. Results. During the 2.5 year study period, 226 patients had an episode of TCC bacteraemia that met inclusion criteria, and 3 month follow-up data were available in 219 episodes. Treatment failure, defined as recurrent TCC bacteraemia with the same organism or death from sepsis, occurred in 26 patients (12%). Infectious complications (such as endocarditis, osteomyelitis, etc.) occurred in 16 patients (7%), bacteraemia with a different organism occurred in 19 patients (9%), and death from sepsis occurred in eight patients (4%). Significant predictors of treatment failure (by univariate analysis) were TCC salvage, and infection with Staphylococcus aureus, (OR = 4.2, P = 0.002; and OR = 3.3, P = 0.02, respectively). TCC salvage, when used in episodes of S. aureus bacteraemia, was associated with an 8-fold higher risk of treatment failure (P = 0.001). The presence of an abnormal TCC exit site was associated with a significantly higher rate of death from sepsis, (OR = 7, P = 0.001). Outcomes (treatment failure and infectious complications) did not differ among bacteraemic episodes where the TCC was exchanged over a guidewire compared to those in which the TCC was immediately removed followed by delayed reinsertion. In the multivariate analysis, adjusted for potential confounding covariates, the only significant predictors of treatment failure after an episode of TCC bacteraemia were TCC salvage (OR = 5.4, P = 0.003), and S. aureus (OR = 4.2, P = 0.002). In a multivariate analysis, controlling for TCC management, the only variable that was significantly associated with the development of an infectious complication was infection with S. aureus (OR = 3.5, P = 0.02). Conclusions. We have shown, using multivariate analysis and adjusting for potential confounding factors, that the use of TCC s
doi_str_mv 10.1093/ndt/gfi104
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67778843</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1016000831</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-fbe66ddaced9606309c60f61714d1b608bff6fc909ad8acf5feac58aac272c463</originalsourceid><addsrcrecordid>eNqFkU9rFTEUxYMo9lnd-AEkCLoQxyaTTDJxJ6X1CUURKoqbcCd_bNqZ5JnMQN_C724e72HRjasL9_w43HMPQk8peUOJYifRzic_fKCE30MrygVpWtZ399GqirQhHVFH6FEp14QQ1Ur5EB1RwblqFVuhX5dLjG4cncVX4KZkA4zbEgo2MF-52WU8gKmjagHe4hzKDfZ1k3LBPv2l4uzMkrOLxr3GIXpn5pCW6pSmzRiqX0ixYIgWTynPMIZ5-xg98DAW9-Qwj9GX87PL03Vz8en9h9N3F43hXM6NH5wQ1oJxVgkiGFFGEC-opNzSQZB-8F54o4gC24PxnXdguh7AtLI1XLBj9HLvu8np5-LKrKdQTI0N0dUTtZBS9j1n_wXb-kPeiR34_B_wOi051hC6pT0VSipaoVd7yORUSnZeb3KYIG81JXpXna7V6X11FX52cFyGydk79NBVBV4cACgGRp8hmlDuOCkJ69XOqNlzoczu9o8O-abmZLLT62_f9edzysT641e9Zr8B4hi0_Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>218169791</pqid></control><display><type>article</type><title>Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality</title><source>MEDLINE</source><source>Oxford Journals - Connect here FIRST to enable access</source><source>Free E-Journal (出版社公開部分のみ)</source><source>Alma/SFX Local Collection</source><creator>Mokrzycki, Michele H. ; Zhang, Meilin ; Cohen, Hillel ; Golestaneh, Ladan ; Laut, Jeffrey M. ; Rosenberg, Stuart O.</creator><creatorcontrib>Mokrzycki, Michele H. ; Zhang, Meilin ; Cohen, Hillel ; Golestaneh, Ladan ; Laut, Jeffrey M. ; Rosenberg, Stuart O.</creatorcontrib><description>Background. Infection is a serious complication of tunnelled cuffed catheter (TCC) use and is associated with high complication and mortality rates. Although attempts at TCC salvage after bacteraemia have been associated with high rates of recurrent bacteraemia, there have been no large studies in which multivariate analysis has been performed to control for confounding factors such as infecting organisms, diabetes, etc. Methods. A prospective observational study was performed in chronic HD patients dialyzing with a TCC at seven outpatient HD centers. All patients diagnosed with TCC bacteraemia were observed for 3 months following initial presentation and outcomes were recorded. Results. During the 2.5 year study period, 226 patients had an episode of TCC bacteraemia that met inclusion criteria, and 3 month follow-up data were available in 219 episodes. Treatment failure, defined as recurrent TCC bacteraemia with the same organism or death from sepsis, occurred in 26 patients (12%). Infectious complications (such as endocarditis, osteomyelitis, etc.) occurred in 16 patients (7%), bacteraemia with a different organism occurred in 19 patients (9%), and death from sepsis occurred in eight patients (4%). Significant predictors of treatment failure (by univariate analysis) were TCC salvage, and infection with Staphylococcus aureus, (OR = 4.2, P = 0.002; and OR = 3.3, P = 0.02, respectively). TCC salvage, when used in episodes of S. aureus bacteraemia, was associated with an 8-fold higher risk of treatment failure (P = 0.001). The presence of an abnormal TCC exit site was associated with a significantly higher rate of death from sepsis, (OR = 7, P = 0.001). Outcomes (treatment failure and infectious complications) did not differ among bacteraemic episodes where the TCC was exchanged over a guidewire compared to those in which the TCC was immediately removed followed by delayed reinsertion. In the multivariate analysis, adjusted for potential confounding covariates, the only significant predictors of treatment failure after an episode of TCC bacteraemia were TCC salvage (OR = 5.4, P = 0.003), and S. aureus (OR = 4.2, P = 0.002). In a multivariate analysis, controlling for TCC management, the only variable that was significantly associated with the development of an infectious complication was infection with S. aureus (OR = 3.5, P = 0.02). Conclusions. We have shown, using multivariate analysis and adjusting for potential confounding factors, that the use of TCC salvage and S. aureus are independent risk factors for treatment failure after an episode of TCC bacteraemia, and that S. aureus is an independent risk factor for developing an infectious complication. An infected-appearing TCC exit site is associated with a higher mortality rate. Episodes of TCC bacteraemia treated using TCC salvage are associated with the highest treatment failure rates. TCC guidewire exchange can be an acceptable practice, unless severe exit site or tunnel infection is present.</description><identifier>ISSN: 0931-0509</identifier><identifier>EISSN: 1460-2385</identifier><identifier>DOI: 10.1093/ndt/gfi104</identifier><identifier>PMID: 16449293</identifier><identifier>CODEN: NDTREA</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; bacteraemia ; Bacteremia - drug therapy ; Bacteremia - etiology ; Bacteremia - mortality ; Biological and medical sciences ; catheter ; Catheterization, Central Venous - adverse effects ; Emergency and intensive care: renal failure. Dialysis management ; Female ; haemodialysis ; Humans ; Intensive care medicine ; Male ; Medical sciences ; Middle Aged ; Nephrology. Urinary tract diseases ; Nephropathies. Renovascular diseases. Renal failure ; Prospective Studies ; Renal Dialysis - adverse effects ; Renal failure ; Risk Factors ; sepsis ; Staphylococcal Infections - drug therapy ; Staphylococcal Infections - etiology ; Staphylococcal Infections - mortality ; Staphylococcus aureus ; Staphylococcus aureus - pathogenicity ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the urinary system ; Survival Rate ; Treatment Outcome ; tunnelled catheter</subject><ispartof>Nephrology, dialysis, transplantation, 2006-04, Vol.21 (4), p.1024-1031</ispartof><rights>2006 INIST-CNRS</rights><rights>Copyright Oxford University Press(England) Apr 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-fbe66ddaced9606309c60f61714d1b608bff6fc909ad8acf5feac58aac272c463</citedby><cites>FETCH-LOGICAL-c447t-fbe66ddaced9606309c60f61714d1b608bff6fc909ad8acf5feac58aac272c463</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17703894$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16449293$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mokrzycki, Michele H.</creatorcontrib><creatorcontrib>Zhang, Meilin</creatorcontrib><creatorcontrib>Cohen, Hillel</creatorcontrib><creatorcontrib>Golestaneh, Ladan</creatorcontrib><creatorcontrib>Laut, Jeffrey M.</creatorcontrib><creatorcontrib>Rosenberg, Stuart O.</creatorcontrib><title>Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality</title><title>Nephrology, dialysis, transplantation</title><addtitle>Nephrol. Dial. Transplant</addtitle><description>Background. Infection is a serious complication of tunnelled cuffed catheter (TCC) use and is associated with high complication and mortality rates. Although attempts at TCC salvage after bacteraemia have been associated with high rates of recurrent bacteraemia, there have been no large studies in which multivariate analysis has been performed to control for confounding factors such as infecting organisms, diabetes, etc. Methods. A prospective observational study was performed in chronic HD patients dialyzing with a TCC at seven outpatient HD centers. All patients diagnosed with TCC bacteraemia were observed for 3 months following initial presentation and outcomes were recorded. Results. During the 2.5 year study period, 226 patients had an episode of TCC bacteraemia that met inclusion criteria, and 3 month follow-up data were available in 219 episodes. Treatment failure, defined as recurrent TCC bacteraemia with the same organism or death from sepsis, occurred in 26 patients (12%). Infectious complications (such as endocarditis, osteomyelitis, etc.) occurred in 16 patients (7%), bacteraemia with a different organism occurred in 19 patients (9%), and death from sepsis occurred in eight patients (4%). Significant predictors of treatment failure (by univariate analysis) were TCC salvage, and infection with Staphylococcus aureus, (OR = 4.2, P = 0.002; and OR = 3.3, P = 0.02, respectively). TCC salvage, when used in episodes of S. aureus bacteraemia, was associated with an 8-fold higher risk of treatment failure (P = 0.001). The presence of an abnormal TCC exit site was associated with a significantly higher rate of death from sepsis, (OR = 7, P = 0.001). Outcomes (treatment failure and infectious complications) did not differ among bacteraemic episodes where the TCC was exchanged over a guidewire compared to those in which the TCC was immediately removed followed by delayed reinsertion. In the multivariate analysis, adjusted for potential confounding covariates, the only significant predictors of treatment failure after an episode of TCC bacteraemia were TCC salvage (OR = 5.4, P = 0.003), and S. aureus (OR = 4.2, P = 0.002). In a multivariate analysis, controlling for TCC management, the only variable that was significantly associated with the development of an infectious complication was infection with S. aureus (OR = 3.5, P = 0.02). Conclusions. We have shown, using multivariate analysis and adjusting for potential confounding factors, that the use of TCC salvage and S. aureus are independent risk factors for treatment failure after an episode of TCC bacteraemia, and that S. aureus is an independent risk factor for developing an infectious complication. An infected-appearing TCC exit site is associated with a higher mortality rate. Episodes of TCC bacteraemia treated using TCC salvage are associated with the highest treatment failure rates. TCC guidewire exchange can be an acceptable practice, unless severe exit site or tunnel infection is present.</description><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>bacteraemia</subject><subject>Bacteremia - drug therapy</subject><subject>Bacteremia - etiology</subject><subject>Bacteremia - mortality</subject><subject>Biological and medical sciences</subject><subject>catheter</subject><subject>Catheterization, Central Venous - adverse effects</subject><subject>Emergency and intensive care: renal failure. Dialysis management</subject><subject>Female</subject><subject>haemodialysis</subject><subject>Humans</subject><subject>Intensive care medicine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Nephropathies. Renovascular diseases. Renal failure</subject><subject>Prospective Studies</subject><subject>Renal Dialysis - adverse effects</subject><subject>Renal failure</subject><subject>Risk Factors</subject><subject>sepsis</subject><subject>Staphylococcal Infections - drug therapy</subject><subject>Staphylococcal Infections - etiology</subject><subject>Staphylococcal Infections - mortality</subject><subject>Staphylococcus aureus</subject><subject>Staphylococcus aureus - pathogenicity</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the urinary system</subject><subject>Survival Rate</subject><subject>Treatment Outcome</subject><subject>tunnelled catheter</subject><issn>0931-0509</issn><issn>1460-2385</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU9rFTEUxYMo9lnd-AEkCLoQxyaTTDJxJ6X1CUURKoqbcCd_bNqZ5JnMQN_C724e72HRjasL9_w43HMPQk8peUOJYifRzic_fKCE30MrygVpWtZ399GqirQhHVFH6FEp14QQ1Ur5EB1RwblqFVuhX5dLjG4cncVX4KZkA4zbEgo2MF-52WU8gKmjagHe4hzKDfZ1k3LBPv2l4uzMkrOLxr3GIXpn5pCW6pSmzRiqX0ixYIgWTynPMIZ5-xg98DAW9-Qwj9GX87PL03Vz8en9h9N3F43hXM6NH5wQ1oJxVgkiGFFGEC-opNzSQZB-8F54o4gC24PxnXdguh7AtLI1XLBj9HLvu8np5-LKrKdQTI0N0dUTtZBS9j1n_wXb-kPeiR34_B_wOi051hC6pT0VSipaoVd7yORUSnZeb3KYIG81JXpXna7V6X11FX52cFyGydk79NBVBV4cACgGRp8hmlDuOCkJ69XOqNlzoczu9o8O-abmZLLT62_f9edzysT641e9Zr8B4hi0_Q</recordid><startdate>20060401</startdate><enddate>20060401</enddate><creator>Mokrzycki, Michele H.</creator><creator>Zhang, Meilin</creator><creator>Cohen, Hillel</creator><creator>Golestaneh, Ladan</creator><creator>Laut, Jeffrey M.</creator><creator>Rosenberg, Stuart O.</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>20060401</creationdate><title>Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality</title><author>Mokrzycki, Michele H. ; Zhang, Meilin ; Cohen, Hillel ; Golestaneh, Ladan ; Laut, Jeffrey M. ; Rosenberg, Stuart O.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-fbe66ddaced9606309c60f61714d1b608bff6fc909ad8acf5feac58aac272c463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>bacteraemia</topic><topic>Bacteremia - drug therapy</topic><topic>Bacteremia - etiology</topic><topic>Bacteremia - mortality</topic><topic>Biological and medical sciences</topic><topic>catheter</topic><topic>Catheterization, Central Venous - adverse effects</topic><topic>Emergency and intensive care: renal failure. Dialysis management</topic><topic>Female</topic><topic>haemodialysis</topic><topic>Humans</topic><topic>Intensive care medicine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Nephropathies. Renovascular diseases. Renal failure</topic><topic>Prospective Studies</topic><topic>Renal Dialysis - adverse effects</topic><topic>Renal failure</topic><topic>Risk Factors</topic><topic>sepsis</topic><topic>Staphylococcal Infections - drug therapy</topic><topic>Staphylococcal Infections - etiology</topic><topic>Staphylococcal Infections - mortality</topic><topic>Staphylococcus aureus</topic><topic>Staphylococcus aureus - pathogenicity</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the urinary system</topic><topic>Survival Rate</topic><topic>Treatment Outcome</topic><topic>tunnelled catheter</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mokrzycki, Michele H.</creatorcontrib><creatorcontrib>Zhang, Meilin</creatorcontrib><creatorcontrib>Cohen, Hillel</creatorcontrib><creatorcontrib>Golestaneh, Ladan</creatorcontrib><creatorcontrib>Laut, Jeffrey M.</creatorcontrib><creatorcontrib>Rosenberg, Stuart O.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Nephrology, dialysis, transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mokrzycki, Michele H.</au><au>Zhang, Meilin</au><au>Cohen, Hillel</au><au>Golestaneh, Ladan</au><au>Laut, Jeffrey M.</au><au>Rosenberg, Stuart O.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality</atitle><jtitle>Nephrology, dialysis, transplantation</jtitle><addtitle>Nephrol. Dial. Transplant</addtitle><date>2006-04-01</date><risdate>2006</risdate><volume>21</volume><issue>4</issue><spage>1024</spage><epage>1031</epage><pages>1024-1031</pages><issn>0931-0509</issn><eissn>1460-2385</eissn><coden>NDTREA</coden><abstract>Background. Infection is a serious complication of tunnelled cuffed catheter (TCC) use and is associated with high complication and mortality rates. Although attempts at TCC salvage after bacteraemia have been associated with high rates of recurrent bacteraemia, there have been no large studies in which multivariate analysis has been performed to control for confounding factors such as infecting organisms, diabetes, etc. Methods. A prospective observational study was performed in chronic HD patients dialyzing with a TCC at seven outpatient HD centers. All patients diagnosed with TCC bacteraemia were observed for 3 months following initial presentation and outcomes were recorded. Results. During the 2.5 year study period, 226 patients had an episode of TCC bacteraemia that met inclusion criteria, and 3 month follow-up data were available in 219 episodes. Treatment failure, defined as recurrent TCC bacteraemia with the same organism or death from sepsis, occurred in 26 patients (12%). Infectious complications (such as endocarditis, osteomyelitis, etc.) occurred in 16 patients (7%), bacteraemia with a different organism occurred in 19 patients (9%), and death from sepsis occurred in eight patients (4%). Significant predictors of treatment failure (by univariate analysis) were TCC salvage, and infection with Staphylococcus aureus, (OR = 4.2, P = 0.002; and OR = 3.3, P = 0.02, respectively). TCC salvage, when used in episodes of S. aureus bacteraemia, was associated with an 8-fold higher risk of treatment failure (P = 0.001). The presence of an abnormal TCC exit site was associated with a significantly higher rate of death from sepsis, (OR = 7, P = 0.001). Outcomes (treatment failure and infectious complications) did not differ among bacteraemic episodes where the TCC was exchanged over a guidewire compared to those in which the TCC was immediately removed followed by delayed reinsertion. In the multivariate analysis, adjusted for potential confounding covariates, the only significant predictors of treatment failure after an episode of TCC bacteraemia were TCC salvage (OR = 5.4, P = 0.003), and S. aureus (OR = 4.2, P = 0.002). In a multivariate analysis, controlling for TCC management, the only variable that was significantly associated with the development of an infectious complication was infection with S. aureus (OR = 3.5, P = 0.02). Conclusions. We have shown, using multivariate analysis and adjusting for potential confounding factors, that the use of TCC salvage and S. aureus are independent risk factors for treatment failure after an episode of TCC bacteraemia, and that S. aureus is an independent risk factor for developing an infectious complication. An infected-appearing TCC exit site is associated with a higher mortality rate. Episodes of TCC bacteraemia treated using TCC salvage are associated with the highest treatment failure rates. TCC guidewire exchange can be an acceptable practice, unless severe exit site or tunnel infection is present.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>16449293</pmid><doi>10.1093/ndt/gfi104</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0931-0509
ispartof Nephrology, dialysis, transplantation, 2006-04, Vol.21 (4), p.1024-1031
issn 0931-0509
1460-2385
language eng
recordid cdi_proquest_miscellaneous_67778843
source MEDLINE; Oxford Journals - Connect here FIRST to enable access; Free E-Journal (出版社公開部分のみ); Alma/SFX Local Collection
subjects Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
bacteraemia
Bacteremia - drug therapy
Bacteremia - etiology
Bacteremia - mortality
Biological and medical sciences
catheter
Catheterization, Central Venous - adverse effects
Emergency and intensive care: renal failure. Dialysis management
Female
haemodialysis
Humans
Intensive care medicine
Male
Medical sciences
Middle Aged
Nephrology. Urinary tract diseases
Nephropathies. Renovascular diseases. Renal failure
Prospective Studies
Renal Dialysis - adverse effects
Renal failure
Risk Factors
sepsis
Staphylococcal Infections - drug therapy
Staphylococcal Infections - etiology
Staphylococcal Infections - mortality
Staphylococcus aureus
Staphylococcus aureus - pathogenicity
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the urinary system
Survival Rate
Treatment Outcome
tunnelled catheter
title Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T08%3A12%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tunnelled%20haemodialysis%20catheter%20bacteraemia:%20risk%20factors%20for%20bacteraemia%20recurrence,%20infectious%20complications%20and%20mortality&rft.jtitle=Nephrology,%20dialysis,%20transplantation&rft.au=Mokrzycki,%20Michele%20H.&rft.date=2006-04-01&rft.volume=21&rft.issue=4&rft.spage=1024&rft.epage=1031&rft.pages=1024-1031&rft.issn=0931-0509&rft.eissn=1460-2385&rft.coden=NDTREA&rft_id=info:doi/10.1093/ndt/gfi104&rft_dat=%3Cproquest_cross%3E1016000831%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=218169791&rft_id=info:pmid/16449293&rfr_iscdi=true